ZA200602759B - Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation - Google Patents
Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation Download PDFInfo
- Publication number
- ZA200602759B ZA200602759B ZA200602759A ZA200602759A ZA200602759B ZA 200602759 B ZA200602759 B ZA 200602759B ZA 200602759 A ZA200602759 A ZA 200602759A ZA 200602759 A ZA200602759 A ZA 200602759A ZA 200602759 B ZA200602759 B ZA 200602759B
- Authority
- ZA
- South Africa
- Prior art keywords
- implant
- barrier
- coating
- cells
- semipermeable
- Prior art date
Links
- 239000007943 implant Substances 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 17
- 210000002808 connective tissue Anatomy 0.000 title abstract description 16
- 230000015572 biosynthetic process Effects 0.000 title abstract description 5
- 238000002513 implantation Methods 0.000 title description 4
- 230000004888 barrier function Effects 0.000 claims abstract description 72
- 238000000576 coating method Methods 0.000 claims abstract description 62
- 239000011248 coating agent Substances 0.000 claims abstract description 60
- 229910052751 metal Inorganic materials 0.000 claims abstract description 25
- 239000002184 metal Substances 0.000 claims abstract description 25
- 238000009792 diffusion process Methods 0.000 claims abstract description 24
- 230000000975 bioactive effect Effects 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 18
- 239000010936 titanium Substances 0.000 claims abstract description 17
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 14
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 14
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 27
- 102000004877 Insulin Human genes 0.000 claims description 14
- 108090001061 Insulin Proteins 0.000 claims description 14
- 229940125396 insulin Drugs 0.000 claims description 14
- 235000015097 nutrients Nutrition 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 8
- 210000000056 organ Anatomy 0.000 claims description 8
- 239000001301 oxygen Substances 0.000 claims description 8
- 229910052760 oxygen Inorganic materials 0.000 claims description 8
- 241001465754 Metazoa Species 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 230000008020 evaporation Effects 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 4
- 238000001802 infusion Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000004544 sputter deposition Methods 0.000 claims description 3
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 2
- 229910045601 alloy Inorganic materials 0.000 claims description 2
- 239000000956 alloy Substances 0.000 claims description 2
- 229910052715 tantalum Inorganic materials 0.000 claims description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 claims description 2
- 229910052726 zirconium Inorganic materials 0.000 claims description 2
- 230000012010 growth Effects 0.000 abstract description 8
- 210000000496 pancreas Anatomy 0.000 abstract description 3
- 210000004379 membrane Anatomy 0.000 description 33
- 239000012528 membrane Substances 0.000 description 33
- 210000001519 tissue Anatomy 0.000 description 28
- 238000000502 dialysis Methods 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 15
- 239000008103 glucose Substances 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000011148 porous material Substances 0.000 description 13
- 210000004204 blood vessel Anatomy 0.000 description 12
- 206010016654 Fibrosis Diseases 0.000 description 8
- 230000004761 fibrosis Effects 0.000 description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 7
- 229940072056 alginate Drugs 0.000 description 7
- 235000010443 alginic acid Nutrition 0.000 description 7
- 230000032258 transport Effects 0.000 description 7
- 229920000615 alginic acid Polymers 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 238000000151 deposition Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000011888 foil Substances 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004153 islets of langerhan Anatomy 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004873 anchoring Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 239000003114 blood coagulation factor Substances 0.000 description 1
- 229940077731 carbohydrate nutrients Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000009388 chemical precipitation Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000008473 connective tissue growth Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003352 fibrogenic effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011694 lewis rat Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000001690 micro-dialysis Methods 0.000 description 1
- 210000001915 nurse cell Anatomy 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 238000005240 physical vapour deposition Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 229940070376 protein Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000007998 vessel formation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- External Artificial Organs (AREA)
- Slide Fasteners, Snap Fasteners, And Hook Fasteners (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0302599A SE526959C2 (sv) | 2003-10-02 | 2003-10-02 | Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200602759B true ZA200602759B (en) | 2007-06-27 |
Family
ID=29247003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200602759A ZA200602759B (en) | 2003-10-02 | 2004-10-04 | Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7955613B2 (no) |
| EP (1) | EP1667746B1 (no) |
| JP (1) | JP4837563B2 (no) |
| KR (1) | KR101181535B1 (no) |
| CN (1) | CN100536937C (no) |
| AT (1) | ATE405301T1 (no) |
| AU (1) | AU2004275685B2 (no) |
| BR (1) | BRPI0415004A (no) |
| CA (1) | CA2539150C (no) |
| DE (1) | DE602004016008D1 (no) |
| DK (1) | DK1667746T3 (no) |
| ES (1) | ES2313072T3 (no) |
| HK (1) | HK1095542A1 (no) |
| IL (1) | IL174488A0 (no) |
| MX (1) | MXPA06003665A (no) |
| NO (1) | NO328180B1 (no) |
| NZ (1) | NZ546775A (no) |
| PL (1) | PL1667746T3 (no) |
| PT (1) | PT1667746E (no) |
| RS (1) | RS20060235A (no) |
| RU (1) | RU2349349C2 (no) |
| SE (1) | SE526959C2 (no) |
| SI (1) | SI1667746T1 (no) |
| UA (1) | UA81982C2 (no) |
| WO (1) | WO2005030283A1 (no) |
| ZA (1) | ZA200602759B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE515227C2 (sv) | 1999-04-28 | 2001-07-02 | Bruce Medical Ab | Kropp för åstadkommande av in- och tillväxt av benvävnad och/ eller bindväv och sätt för framställning av kroppen |
| JP4543152B2 (ja) * | 2004-08-20 | 2010-09-15 | 独立行政法人産業技術総合研究所 | 透明チタン被覆生体適合化材料 |
| WO2008103101A1 (en) * | 2007-02-19 | 2008-08-28 | Ticapex Ab | Implant assembly |
| CA2680321C (en) * | 2007-03-09 | 2016-05-03 | The University Of Akron | Bio-artificial pancreas and a procedure for preparation of same |
| NZ583430A (en) | 2007-08-23 | 2012-06-29 | Intrexon Corp | Methods and compositions for diagnosing disease via detecting reporter gene expression |
| CA2715080C (en) | 2007-09-28 | 2021-09-28 | Intrexon Corporation | Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof |
| RU2525737C1 (ru) * | 2013-05-22 | 2014-08-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) | Способ изготовления внутрикостного стоматологического имплантата |
| RU2526252C1 (ru) * | 2013-05-30 | 2014-08-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) | Способ изготовления внутрикостных имплантатов с многослойным покрытием |
| JP7088564B2 (ja) * | 2016-11-10 | 2022-06-21 | ヴィアサイト，インコーポレイテッド | 細胞送達装置におけるｐｄｘ１膵臓内胚葉細胞及びその方法 |
| JP7084566B2 (ja) * | 2017-05-29 | 2022-06-15 | 創生ライフサイエンス株式会社 | 生体適合性高分子材料のマーキング方法 |
| CA3155905A1 (en) | 2019-09-27 | 2021-04-01 | Isla Technologies, Inc. | BIOARTIFICIAL PANCREAS |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752292A (en) * | 1983-01-24 | 1988-06-21 | Icu Medical, Inc. | Medical connector |
| SE450623B (sv) * | 1984-11-07 | 1987-07-13 | Dan Lundgren | Element for kontrollerad vevnadsinvext i kirurgiskt intervenerade omraden |
| US5632779A (en) * | 1989-07-25 | 1997-05-27 | Smith & Nephew, Inc. | Zirconium oxide and zirconium nitride coated vascular grafts |
| KR0169495B1 (ko) * | 1990-10-31 | 1999-01-15 | 쥐. 마샬 애비 | 폐쇄 혈관신생 이식 물질 |
| EP0585368B1 (en) * | 1991-04-25 | 1997-08-06 | Brown University Research Foundation | Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| US5429821A (en) | 1992-05-29 | 1995-07-04 | The Regents Of The University Of California | Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use |
| US5387327A (en) * | 1992-10-19 | 1995-02-07 | Duquesne University Of The Holy Ghost | Implantable non-enzymatic electrochemical glucose sensor |
| RU2040277C1 (ru) | 1992-12-27 | 1995-07-25 | Товарищество с ограниченной ответственностью "МиТ" (Медицина и Технология) | Способ изготовления материала для имплантата с электретными свойствами для остеосинтеза |
| US5876742A (en) * | 1994-01-24 | 1999-03-02 | The Regents Of The University Of California | Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof |
| AUPM425294A0 (en) * | 1994-03-04 | 1994-03-31 | Australian National University, The | In-vitro angiogenesis assay |
| DE69630266T2 (de) * | 1995-06-07 | 2004-09-09 | W.L. Gore & Associates, Inc., Newark | Implantierbare aufnahmevorrichtung für ein therapeutisches gerät |
| US5855613A (en) * | 1995-10-13 | 1999-01-05 | Islet Sheet Medical, Inc. | Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change |
| RU2113830C1 (ru) | 1996-04-02 | 1998-06-27 | Самарский государственный аэрокосмический университет им.С.П.Королева | Зубной имплантат |
| RU2109495C1 (ru) | 1996-07-19 | 1998-04-27 | Наум Абрамович Иофис | Искусственный клапан сердца и способ его изготовления |
| RU2117456C1 (ru) | 1996-11-18 | 1998-08-20 | Жусев Андрей Иванович | Пластиночный эндооссальный имплантант |
| RU2142867C1 (ru) | 1998-02-23 | 1999-12-20 | Суслов Анатолий Григорьевич | Комбинированный (режуще-деформирующий) метчик |
| RU2157245C1 (ru) | 1999-03-05 | 2000-10-10 | Антонив Василий Федорович | Способ изготовления имплантатов |
| AU3724900A (en) * | 1999-03-05 | 2000-09-21 | Louis R. Matson | Surface-modified bioactive surgical implants suppressing tissue growth |
| RU2185127C2 (ru) | 1999-07-19 | 2002-07-20 | Нижегородская государственная медицинская академия | Винтовой зубной имплантат |
| DE19950386A1 (de) * | 1999-10-19 | 2001-05-10 | Miladin Lazarov | Biokompatibler Gegenstand |
| US20020000404A1 (en) * | 2000-03-17 | 2002-01-03 | Michael Mutsakis | Filtration element for severe service applications |
| JP2003530926A (ja) * | 2000-04-14 | 2003-10-21 | ヴァージニア テック インテレクチュアル プロパティーズ インコーポレイテッド | 物質の生体適合性を増強するための自己集合した薄膜コーティング |
| RU2191607C2 (ru) | 2000-06-23 | 2002-10-27 | Гюнтер Виктор Эдуардович | Носитель клеточных культур искусственных внутренних органов |
| AU2001273234A1 (en) | 2000-07-05 | 2002-01-14 | Islet Technology, Inc. | Method and system for consistent and effective encapsulation of biological material |
| DK1381402T3 (da) | 2001-04-27 | 2010-03-08 | Vivoxid Oy | Fremgangsmåde til forbedring af blødvævsmodtagelse og implantater der gør brug af denne fremgangsmåde |
| US7163688B2 (en) * | 2001-06-22 | 2007-01-16 | Alza Corporation | Osmotic implant with membrane and membrane retention means |
| SE0200269D0 (sv) | 2002-01-31 | 2002-01-31 | Ellem Bioteknik Ab | Material for implantation |
| US7458991B2 (en) * | 2002-02-08 | 2008-12-02 | Howmedica Osteonics Corp. | Porous metallic scaffold for tissue ingrowth |
-
2003
- 2003-10-02 SE SE0302599A patent/SE526959C2/sv not_active IP Right Cessation
-
2004
- 2004-04-10 UA UAA200604785A patent/UA81982C2/uk unknown
- 2004-10-04 WO PCT/SE2004/001418 patent/WO2005030283A1/en active Application Filing
- 2004-10-04 AU AU2004275685A patent/AU2004275685B2/en not_active Ceased
- 2004-10-04 CA CA2539150A patent/CA2539150C/en not_active Expired - Fee Related
- 2004-10-04 KR KR1020067008504A patent/KR101181535B1/ko not_active IP Right Cessation
- 2004-10-04 JP JP2006532233A patent/JP4837563B2/ja not_active Expired - Fee Related
- 2004-10-04 US US10/574,114 patent/US7955613B2/en not_active Expired - Fee Related
- 2004-10-04 NZ NZ546775A patent/NZ546775A/en not_active IP Right Cessation
- 2004-10-04 RU RU2006114350/15A patent/RU2349349C2/ru not_active IP Right Cessation
- 2004-10-04 AT AT04775510T patent/ATE405301T1/de active
- 2004-10-04 ES ES04775510T patent/ES2313072T3/es active Active
- 2004-10-04 EP EP04775510A patent/EP1667746B1/en active Active
- 2004-10-04 MX MXPA06003665A patent/MXPA06003665A/es active IP Right Grant
- 2004-10-04 DE DE602004016008T patent/DE602004016008D1/de active Active
- 2004-10-04 PL PL04775510T patent/PL1667746T3/pl unknown
- 2004-10-04 ZA ZA200602759A patent/ZA200602759B/en unknown
- 2004-10-04 SI SI200430926T patent/SI1667746T1/sl unknown
- 2004-10-04 BR BRPI0415004-0A patent/BRPI0415004A/pt not_active IP Right Cessation
- 2004-10-04 CN CNB200480028566XA patent/CN100536937C/zh not_active Expired - Fee Related
- 2004-10-04 DK DK04775510T patent/DK1667746T3/da active
- 2004-10-04 RS YUP-2006/0235A patent/RS20060235A/sr unknown
- 2004-10-04 PT PT04775510T patent/PT1667746E/pt unknown
-
2006
- 2006-03-22 IL IL174488A patent/IL174488A0/en not_active IP Right Cessation
- 2006-04-28 NO NO20061899A patent/NO328180B1/no not_active IP Right Cessation
-
2007
- 2007-01-17 HK HK07100590.7A patent/HK1095542A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO328180B1 (no) | Kunstig biologisk implantat og dets bruk og fremgangsmate for redusering av risikoen for dannelse av bindevev etter implantasjon | |
| KR0169495B1 (ko) | 폐쇄 혈관신생 이식 물질 | |
| EP2125056B1 (en) | Implant assembly | |
| US5324518A (en) | Implantable structure for containing substances for delivery to a body | |
| US20040247640A1 (en) | Nitric oxide releasing eptfe coated medical device sandwich | |
| JP4282106B2 (ja) | 医療用具のための薬剤放出コーティング | |
| WO1991000119A1 (en) | Implantable device | |
| US10092387B2 (en) | Implantable device for retaining live cells and providing nutrients thereto | |
| JPH06509812A (ja) | 生物人工内分泌装置 | |
| CN115697300A (zh) | 用于医疗装置的膜 | |
| KR102131101B1 (ko) | 선택적 플라즈마 에칭법에 의한, 혈액적합성이 향상된 ePTFE 인공혈관의 제조방법 | |
| WO1993023013A1 (en) | Extravascular system for infusion of soluble substances | |
| Richardson et al. | Hybrid organs | |
| Moussy et al. | Analysis of glucose and insulin mass transfer in a novel 2-channel bioartificial pancreas | |
| Paul et al. | Discussion: Artificial Organs |